Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
about
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Molecular changes in the progression of Barrett's oesophagusSecondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trialTreatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes.Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.Ablating Barrett's metaplastic epithelium: are the techniques ready for clinical use?Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Effect of medical and surgical treatment of Barrett's metaplasiaAcid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisChemoprevention of esophageal adenocarcinomaAre we making progress in diagnosing and preventing gastrointestinal cancers?American Gastroenterological Association technical review on the management of Barrett's esophagusPredictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.Current status and future perspectives on the etiology of esophageal adenocarcinoma.Barrett's Esophagus: Emerging Knowledge and Management StrategiesPredictors of progression in Barrett's esophagus: current knowledge and future directionsProton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.Chemoprevention of gastrointestinal cancer: the reality and the dream.The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Barrett's esophagus: where do we stand?Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.Medication usage and the risk of neoplasia in patients with Barrett's esophagus.Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...?Acid peptic diseases: pharmacological approach to treatment.Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.Esophageal cancer: The latest on chemoprevention and state of the art therapies.Screening and Preventive Strategies in Esophagogastric Cancer.Inflammation-related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models.p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients.The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.Precision care for Barrett's esophagus
P2860
Q27332349-A21FB4C3-D2BD-4359-840E-332D34F0023AQ28219148-4982543E-E908-4422-A5E7-33A172691EEDQ28222007-215C61D9-401F-4864-88D4-0BC0DBB2C14EQ30472472-3D34F699-FB65-479F-B250-1057610EA814Q30619561-2C60B15E-955D-49F9-9598-D2DDD5622DF0Q33253757-6FC8A3E8-DD80-43F4-8BC1-76F66C71367DQ33905941-C4F8D52A-3B77-4D32-8463-3B179F698016Q33948451-2F46003A-AED5-44DF-9193-B9A98083F2BCQ34063700-51C14BC2-41B1-4EA8-BFA5-6CDFA1840294Q34352867-07AE486D-39CB-4D94-9B74-0640FC1377C7Q34408890-005710A2-53F0-413D-A2BE-2119F121A63BQ34409199-E2019CF0-6842-4A06-8A82-622B9EF388ABQ35673305-59A9CF97-8494-4A6A-AA00-60172098D341Q35861879-5716EA1D-D5E0-415F-BC1F-DD2BB6796221Q35972032-03DB9251-3C79-4098-AA04-B2E3CD920F27Q36014649-0566364B-3EE4-4BE2-9B47-3DFA7FCC0D47Q36127891-3E2DFD8D-121A-473E-91B0-FFE6896D628FQ36245569-806BD7F3-2356-4E1B-B5C2-2B2F928DB05DQ36279164-2215ED66-2E97-454C-BD79-DC25B1420AD6Q36715105-71C6DF59-7B0D-46DF-AB2F-788F8069DCA9Q36860466-0C49B790-75D6-433D-AA44-E38FF9B11C24Q37018314-CE02DB31-D057-45B8-8B32-E820F30F2818Q37243629-4459AC54-4C42-413E-9F92-55A2E4615D56Q37378002-AC568769-CF63-4975-85EC-4190EF4EC05FQ37463812-9F48E01A-2942-43CF-8FB0-0F926203D353Q37463822-345C6014-EBA2-43B9-9B58-4BC5C01CE01AQ37913063-FA86AE78-87F7-40A2-84B2-74381BA95EAEQ37967701-878C32B5-722F-45EB-AF61-A28F6E484533Q38938101-F7B3831D-4E6F-488F-BB41-749AC3F3E207Q39171528-DC27060C-7FC2-41AC-96C9-921AE5FB84D5Q41783023-F8F712BD-C564-4EA4-9363-C5B5B37DDCE3Q48207467-40901990-58E4-443C-90B0-449110ED11ECQ55224609-B0D35E45-C193-4F8C-86C4-0FD91136F252Q58554442-3F226EE8-8BCC-4003-A579-E64DB8CAC3D4
P2860
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@ast
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@en
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@nl
type
label
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@ast
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@en
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@nl
prefLabel
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@ast
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@en
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@nl
P2093
P1476
Proton-pump inhibitor therapy ...... ents with Barrett's oesophagus
@en
P2093
Anthony C Clarke
Bruce Shadbolt
Graham L Kaye
Louise Chiragakis
Lybus C Hillman
P304
P407
P577
2004-04-19T00:00:00Z